Versor Investments LP Has $2.70 Million Holdings in HealthEquity, Inc. $HQY

Key Points

• Versor Investments LP increased its holdings in HealthEquity, Inc. by 235.1%, owning 30,492 shares valued at approximately $2.70 million following an additional purchase of 21,392 shares.
• HealthEquity's recent earnings report showed an EPS of $0.97, surpassing expectations of $0.81, alongside revenue of $330.80 million compared to forecasts of $322.25 million.
• In July, Wall Street Zen upgraded HealthEquity's rating from "hold" to "buy," and the stock has received a consensus average rating of "Buy" with a target price of $118.55.

Versor Investments LP grew its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 235.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 30,492 shares of the company's stock after acquiring an additional 21,392 shares during the period. HealthEquity accounts for approximately 0.4% of Versor Investments LP's holdings, making the stock its 21st largest position. Versor Investments LP's holdings in HealthEquity were worth $2,695,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Bank of Montreal Can lifted its position in HealthEquity by 11.7% during the 4th quarter. Bank of Montreal Can now owns 12,756 shares of the company's stock worth $1,224,000 after acquiring an additional 1,338 shares during the last quarter. Barclays PLC boosted its stake in HealthEquity by 20.3% during the 4th quarter. Barclays PLC now owns 200,341 shares of the company's stock valued at $19,223,000 after purchasing an additional 33,849 shares during the period. Mariner LLC boosted its stake in HealthEquity by 1.8% during the 4th quarter. Mariner LLC now owns 13,309 shares of the company's stock valued at $1,277,000 after purchasing an additional 239 shares during the period. XTX Topco Ltd acquired a new stake in HealthEquity in the 4th quarter valued at approximately $432,000. Finally, Guggenheim Capital LLC increased its position in HealthEquity by 27.2% in the 4th quarter. Guggenheim Capital LLC now owns 14,347 shares of the company's stock worth $1,377,000 after buying an additional 3,065 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 58,000 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the transaction, the executive vice president directly owned 75,689 shares of the company's stock, valued at $8,519,553.84. This represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 291,744 shares of company stock worth $32,705,007. 1.50% of the stock is owned by company insiders.

Analyst Ratings Changes

HQY has been the subject of several research reports. Barrington Research increased their price objective on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a research report on Thursday, June 5th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. JMP Securities lifted their price objective on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft increased their target price on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. Finally, Raymond James Financial reaffirmed a "strong-buy" rating and issued a $120.00 price target (up from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $118.55.

HealthEquity Trading Down 0.7%

HealthEquity stock traded down $0.60 during mid-day trading on Friday, hitting $90.46. The stock had a trading volume of 540,867 shares, compared to its average volume of 1,003,831. The stock has a market capitalization of $7.82 billion, a PE ratio of 66.03, a P/E/G ratio of 1.38 and a beta of 0.54. HealthEquity, Inc. has a 12 month low of $73.84 and a 12 month high of $116.65. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a 50-day simple moving average of $97.07 and a two-hundred day simple moving average of $96.80.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. During the same quarter last year, the firm earned $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.